NFJ Investment Group LLC Decreases Stake in The Cooper Companies, Inc. $COO

NFJ Investment Group LLC lessened its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 12.0% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 85,579 shares of the medical device company’s stock after selling 11,719 shares during the quarter. NFJ Investment Group LLC’s holdings in Cooper Companies were worth $7,014,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also made changes to their positions in COO. Wellington Management Group LLP boosted its stake in shares of Cooper Companies by 332.9% in the 3rd quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock valued at $424,043,000 after buying an additional 4,756,178 shares during the period. Generation Investment Management LLP purchased a new position in shares of Cooper Companies in the 4th quarter valued at about $233,539,000. Diamond Hill Capital Management Inc. boosted its stake in shares of Cooper Companies by 479.6% in the 4th quarter. Diamond Hill Capital Management Inc. now owns 3,287,837 shares of the medical device company’s stock valued at $269,471,000 after buying an additional 2,720,594 shares during the period. JANA Partners Management LP purchased a new position in shares of Cooper Companies in the 3rd quarter valued at about $166,917,000. Finally, Capital World Investors boosted its stake in shares of Cooper Companies by 25.7% in the 3rd quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after buying an additional 2,159,233 shares during the period. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on COO shares. Piper Sandler set a $86.00 price objective on Cooper Companies and gave the company an “overweight” rating in a research note on Monday, June 1st. Barclays lifted their price objective on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research note on Friday, March 6th. Weiss Ratings cut Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a research note on Monday, June 8th. Stifel Nicolaus decreased their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Cooper Companies in a research note on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies currently has a consensus rating of “Hold” and an average price target of $82.64.

Cooper Companies Price Performance

COO stock opened at $67.88 on Friday. The business has a 50 day moving average price of $64.79 and a 200 day moving average price of $74.35. The stock has a market cap of $13.24 billion, a price-to-earnings ratio of 57.53, a PEG ratio of 1.78 and a beta of 0.87. The Cooper Companies, Inc. has a fifty-two week low of $58.89 and a fifty-two week high of $89.83. The company has a quick ratio of 0.78, a current ratio of 1.27 and a debt-to-equity ratio of 0.23.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, topping the consensus estimate of $1.10 by $0.11. The firm had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s revenue was up 7.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.96 earnings per share. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts anticipate that The Cooper Companies, Inc. will post 4.63 earnings per share for the current fiscal year.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.